Switch to:
More From Other Websites
BioMarin to Provide Updated Data for BMN 270 in Hemophilia A in Late Breaking Oral Presentation at... Jul 21 2016
Analysts Gauge Alexion Pharmaceuticals’ Return Potential Jul 21 2016
What Are Roche’s Truest Growth Opportunities? Jul 19 2016
Can The Uptrend Continue for with BioMarin Pharmaceutical (BMRN)? Jul 19 2016
BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K, Change in Directors or Principal Officers Jul 19 2016
BioMarin Appoints Two BioPharmaceutical Veterans to Board of Directors, Willard Dere, M.D. and... Jul 18 2016
BioMarin to Host Second Quarter 2016 Financial Results Conference Call and Webcast on Thursday,... Jul 14 2016
Biotech: 'We Would Not Be Surprised to See Volatility Continue' Jul 13 2016
These Four Drugs Were Withdrawn by the CHMP in June Jul 12 2016
The Word on the Street: How Analysts See BioMarin Now Jul 11 2016
Why Did BioMarin’s Share Price Tank after Brexit? Jul 11 2016
Coverage Initiated on Select Biotech Equities Jul 11 2016
New Reports on Recent Market Movers BioMarin Pharmaceutical, SemiLEDs, Fitbit and EZCORP Jul 11 2016
Four high-quality biotech companies trading like risky startups Jul 11 2016
How Much Upside Potential Does Alexion Have? Jul 11 2016
Catabasis' DMD Drug in Phase II Open-Label Extension Study Jul 08 2016
BioMarin Pharmaceutical (BMRN) Jumps: Stock Rises 9.1% Jul 08 2016
BioMarin Pharmaceutical, Inc. breached its 50 day moving average in a Bullish Manner : BMRN-US :... Jul 08 2016


No Entry for this criteria! We are updating our databases daily, please come back later!

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK